KKR & Co. Inc. (NYSE:KKR) shares rose early Thursday after the firm agreed to acquire Medicover India, a multi-specialty hospital network.
Nasdaq futures are down 0.57% while S&P 500 futures have gained 0.13%.
Medicover India’s Hospital Network
Medicover India operates 24 hospitals with about 4,800 beds across South and West India. Founded in 2017, the network covers more than 80 clinical specialties, employs over 1,900 doctors and serves millions of patients annually.
KKR plans to invest in Medicover India’s talent, technology, infrastructure and clinical capabilities. The transaction remains subject to regulatory approvals, and financial terms were not disclosed.
KKR Expands Its Investment Portfolio
The deal expands KKR’s healthcare presence in India, where the firm has invested across healthcare delivery, medical technology and related services.
Globally, KKR has invested more than $20 billion in healthcare since 2004.
Separately, TotalEnergies recently completed the sale of a 50% stake in a largely developed 1.2-gigawatt renewable energy portfolio to KKR at an enterprise value of 1.8 billion euros. The assets are located across Germany, Spain, France and Poland.
KKR Stock: Key Levels And Momentum
At about $106.50, KKR is trading above its 20-day SMA of $100.17, 50-day SMA of $96.70 and 100-day SMA of $96.51. That positioning supports a positive short- and intermediate-term trend.
The main technical test is the 200-day SMA near $106.95. A sustained move above that level could strengthen the bullish setup, while a rejection may trigger a pullback toward nearby support.
Momentum is also improving, with MACD above its signal line and the histogram in positive territory. This suggests buying pressure is gaining strength after the previous decline.
Key Resistance: $106.95 — the 200-day SMA and main breakout level
Key Support: $100.17 — the rising 20-day SMA and nearest support
Analyst Consensus & Recent Actions
The stock carries a Buy rating with an average price forecast of $124.83. Recent analyst moves include:
- Argus Research: Buy (Raises Target to $125.00) (Aug. 4)
- TD Cowen: Hold (Raises Target to $111.00) (Aug. 3)
- BMO Capital: Outperform (Raises Target to $118.00) (Aug. 3)
Top ETFs Holding KKR Stock And Why It Matters
- Tema Listed Private Managers ETF (BATS:PRVT): 5.48% Weight
- Akre Focus ETF (NYSE:AKRE): 8.16% Weight
- Invesco Global Listed Private Equity ETF (NYSE:PSP): 4.70% Weight
Significance: Because KKR carries such a heavy weight in these funds, any significant inflows or outflows for these ETFs will likely force automatic buying or selling of the stock.
KKR Stock Price Activity: KKR shares were trading at $106.51 at the time of publication on Thursday, according to Benzinga Pro data.
Photo by T. Schneider via Shutterstock